Agile Therapeutics reported $-3929000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Adma Biologics ADMA:US USD -14899000 1.14M
Agile Therapeutics AGRX:US USD -3929000 15.74M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
JAZZ PHA JAZZ:US USD -46767000 464.14M
Johnson & Johnson JNJ:US USD 7.42B 655M
Merk MRK:US USD 4.89B 560M
Pacira Pharmaceuticals PCRX:US USD 46.48M 4.25M
Pfizer PFE:US USD 7.38B 3.3B
Therapeuticsmd TXMD:US USD -29225000 142.06M